CRPHS (Cardiac C-Reactive Protein High Sensitive) test, human serum and plasma C-reactive protein (CRP) Determination of levels as quantitative provides. High sensitivity measurement not only inflammatory diseases thanks to its ability, but also evaluation of the risk of coronary heart disease plays an important role. Test, cobas c series and COBAS INTEGRA systems works compatible with.
CRPHS What Does Test Do?
C-Reactive Protein (CRP)occurring in the body inflammation, infection or tissue damage an acute phase reatan rising in the situation. Home high sensitivity CRP (hsCRP) measurement offers valuable information in terms of heart-damar diseases. CRPHS The test is used in evaluation of the following conditions:
- Diagnosis and follow-up of inflammatory diseases
- Monitoring acute and chronic infections
- Tissue damage or post-trailer follow
- Identifying the risk of coronary heart disease in the future
- The prediction of the risk of re-event in patients suffering from stable coronary disease or acute coronary syndrome
Compatible Systems
CRPHS The test can be used in accordance with the following devices:
- cobas c 111
- COBAS INTEGRA 400 News
- cobas c 311
- cobas c 502
- cobas c 503
In these systems CRP levels are measured in both precision and quickly, which strengthens clinical decision support systems.
Advantages of Test
- In vitro Diagnostic Use
- Works with serum and plasma samples
- High sensitivity with latex particle aglutination method
- Biomarker that helps in cardiovascular risk assessment
- Suitable for early diagnosis and long term follow-up
Regulation Information
CRPHS test only in vitro diagnosis for purpose. CE marked and comply with international quality standards. In clinical conditions, it should be used by competent healthcare staff.
